0001493152-24-008930.txt : 20240306 0001493152-24-008930.hdr.sgml : 20240306 20240306060628 ACCESSION NUMBER: 0001493152-24-008930 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240306 DATE AS OF CHANGE: 20240306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SAHAREK JOHN P. CENTRAL INDEX KEY: 0001632091 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35814 FILM NUMBER: 24724293 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL STREET 2: SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER NAME: FORMER CONFORMED NAME: Saharek John DATE OF NAME CHANGE: 20150128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HARROW, INC. CENTRAL INDEX KEY: 0001360214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 450567010 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 615.733.4731 MAIL ADDRESS: STREET 1: 102 WOODMONT BLVD STREET 2: SUITE 610 CITY: NASHVILLE STATE: TN ZIP: 37215 FORMER COMPANY: FORMER CONFORMED NAME: HARROW HEALTH, INC. DATE OF NAME CHANGE: 20181228 FORMER COMPANY: FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20120301 FORMER COMPANY: FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC DATE OF NAME CHANGE: 20070912 4 1 ownership.xml X0508 4 2024-03-01 0 0001360214 HARROW, INC. HROW 0001632091 SAHAREK JOHN P. C/O HARROW, INC. 102 WOODMONT BLVD, SUITE 610 NASHVILLE TN 37205 0 1 0 0 CEO of ImprimisRx 0 Common stock 2024-03-01 4 M 0 5000 8.75 A 254803 D Stock Option (Right to Buy) 8.75 2024-03-01 4 M 0 5000 0 D 2024-03-03 Common Stock 5000 0 D The stock option was granted on March 3, 2014 under the Issuers 2007 Stock Incentive and Awards Plan and the shares subject to the stock option became exercisable over a 3 year period following its grant date. The stock option had an expiration date of March 3, 2024. /s/ John P. Saharek 2024-03-06